Technology News and Research

RSS

Eppendorf announces new addition to BioBLU Single-use Vessel Adaptor Kit portfolio

Eppendorf is proud to announce a new addition to the BioBLU Single-use Vessel Adaptor Kit portfolio. The BioBLU 5c and 14c Adaptor Kits allow BioBLU 5c and 14c Single-use vessels to be used on and controlled by Sartorius® BioStat® B-DCU-II controllers (Heat Blanket configuration only).

3 Jun 2014

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

3 Jun 2014

Salk Institute receives $25 million for cutting-edge biological research

The Salk Institute for Biological Studies has received a $25 million gift from San Diego philanthropist and former Salk trustee Conrad T. Prebys to support cutting-edge biological research on a wide range of diseases.

3 Jun 2014

With healthcare.gov the go-to for 36 states, national exchange becoming a likely possibility

Politico reports that a national enrollment system is what liberals wanted all along, and now, because some GOP governors took a pass on state-run marketplaces while some Democratic states bungled theirs, it's picking up steam. News outlets also report on the latest exchange news from Maryland, Illinois, Minnesota and Washington.

3 Jun 2014

PulseOn collaborates with CSEM to develop wrist-based heart rate monitor

Imagine tracking your heart rate continuously without the need for a classical chest belt. PulseOn, a start-up spun out from Nokia in 2012, has collaborated with CSEM to develop a small and stylish wrist device that allows users to monitor their heart rate accurately and reliably during training and beyond.

3 Jun 2014

CHLA researchers develop novel NextGen sequencing approach for retinoblastoma

Researchers at Children's Hospital Los Angeles have developed a unique next-generation sequencing test for the gene linked to retinoblastoma. The new approach is both more comprehensive and can be conducted in less time than existing tests - enabling early detection of the cancer's genetic cause, which is critical for optimal treatment outcomes.

3 Jun 2014

CluePoints' web-based CSM solution to help sponsors evaluate quality, integrity of clinical trial data

CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has announced a web-based version of its intelligent risk-based monitoring platform that enables sponsors to determine the quality and integrity of their clinical trial data.

3 Jun 2014

Nonadherence triples relapse risk in African American and Asian children in remission from ALL

An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.

3 Jun 2014

EHR solutions provider, ChartLogic, partners with Kareo

ChartLogic, a leader in electronic health record solutions for specialty and primary care physician practices, today announced a partnership with billing solutions powerhouse, Kareo, that will allow the company to offer its clients best-of-breed revenue cycle management.

2 Jun 2014

CRS-207 and chemotherapy combination Phase 1b trial data for unresectable MPM presented at ASCO 2014

Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.

2 Jun 2014

FDA grants OsteoSymbionics 510(k) clearance for sterile processing of ClearShield cranial implant product

OsteoSymbionics, innovative designer and manufacturer of patient-specific craniofacial implants, is pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance for sterile processing of its signature ClearShield™ cranial implant product, utilizing a novel room temperature peracetic acid/hydrogen peroxide (PAA) vacuum vapor sterilization process.

2 Jun 2014

First Edition: June 2, 2014

Today's headlines include reports about state health law implementation activities as well as the next steps regarding the difficulties at the VA health system.

2 Jun 2014

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Medical Equipment Solutions and Applications, Europe's leader in multi-vendor service for Diagnostic Imaging systems, equipment and parts, and Heidelberg-based radiology management company Curagita are joining forces to bring new and broader solutions for a full range of Diagnostic Imaging services to the German healthcare market.

2 Jun 2014

Cherokee Health Systems selects NextGen Healthcare to provide RCM services

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today that Cherokee Health Systems has selected NextGen Healthcare to provide revenue cycle management (RCM) services to re-engineer its business processes, improve financial results and drive business growth.

2 Jun 2014

Scientists use a flash of light to erase and restore memory

Using a flash of light, scientists have inactivated and then reactivated a memory in genetically engineered rats. The study, supported by the National Institutes of Health, is the first cause-and-effect evidence that strengthened connections between neurons are the stuff of memory.

2 Jun 2014

Validic adds several new clients to expand global digital health marketplace

Validic, the healthcare industry's premier technology platform for accessing digital health data, announced today the addition of several new clients and integration partners, as they continue to expand and grow their global digital health marketplace.

2 Jun 2014

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

A UCLA research team has discovered a new hormone called erythroferrone, which regulates the iron supply needed for red blood-cell production.

2 Jun 2014

Myriad myRisk test solves overlap dilemma between hereditary cancer syndromes

Myriad Genetics, Inc. today presented several clinical studies on the Myriad myRisk- Hereditary Cancer test at the 2014 American Society of Clinical Oncology annual meeting in Chicago, Illinois.

2 Jun 2014

ImmunoGen reports favorable clinical results from STARLYTE Phase II trial of SAR3419 for DLBCL

ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).

2 Jun 2014

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.

From Quest Diagnostics 2 Jun 2014

Technology News and Research

Eppendorf announces new addition to BioBLU Single-use Vessel Adaptor Kit portfolio

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Salk Institute receives $25 million for cutting-edge biological research

With healthcare.gov the go-to for 36 states, national exchange becoming a likely possibility

PulseOn collaborates with CSEM to develop wrist-based heart rate monitor

CHLA researchers develop novel NextGen sequencing approach for retinoblastoma

CluePoints' web-based CSM solution to help sponsors evaluate quality, integrity of clinical trial data

Nonadherence triples relapse risk in African American and Asian children in remission from ALL

EHR solutions provider, ChartLogic, partners with Kareo

CRS-207 and chemotherapy combination Phase 1b trial data for unresectable MPM presented at ASCO 2014

FDA grants OsteoSymbionics 510(k) clearance for sterile processing of ClearShield cranial implant product

First Edition: June 2, 2014

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Cherokee Health Systems selects NextGen Healthcare to provide RCM services

Scientists use a flash of light to erase and restore memory

Validic adds several new clients to expand global digital health marketplace

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

Myriad myRisk test solves overlap dilemma between hereditary cancer syndromes

ImmunoGen reports favorable clinical results from STARLYTE Phase II trial of SAR3419 for DLBCL

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News